VIVENTIA
[ Biopharmaceutical preparations for use in immunotherapy, including monoclonal antibodies and fragments thereof and immunofusions and immunoconjugates, particularly immunoligands for the detection and treatment of cancer, biotechnology products for use immunotherapy, including monoclonal antibodies and fragments thereof and immunofusions and immunoconjugates, particularly immunoligands for the detection and treatment of cancer ]
Cancelled · February 5, 2001 · 76205555 ·